These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38464703)

  • 1. Investigation into the safety, and serological responses elicited by delivery of live intranasal vaccines for bovine herpes virus type 1, bovine respiratory syncytial virus, and parainfluenza type 3 in pre-weaned calves.
    Flynn A; McAloon C; Sugrue K; Fitzgerald R; Sheridan C; Cowley B; McAloon C; Kennedy E
    Front Vet Sci; 2024; 11():1283013. PubMed ID: 38464703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and microbiological effects in high-risk beef calves administered intranasal or parenteral modified-live virus vaccines.
    Powledge SA; McAtee TB; Woolums AR; Robin Falkner T; Groves JT; Thoresen M; Valeris-Chacin R; Richeson JT
    J Anim Sci; 2022 Nov; 100(11):. PubMed ID: 35926833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of on-arrival bovine respiratory disease vaccination on ultrasound-confirmed pneumonia and production parameters in male dairy calves: A randomized clinical trial.
    Jourquin S; Lowie T; Debruyne F; Chantillon L; Clinquart J; Pas ML; Boone R; Hoflack G; Vertenten G; Sustronck B; Pardon B
    J Dairy Sci; 2023 Dec; 106(12):9260-9275. PubMed ID: 37641351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternally derived humoral immunity to bovine viral diarrhea virus (BVDV) 1a, BVDV1b, BVDV2, bovine herpesvirus-1, parainfluenza-3 virus bovine respiratory syncytial virus, Mannheimia haemolytica and Pasteurella multocida in beef calves, antibody decline by half-life studies and effect on response to vaccination.
    Fulton RW; Briggs RE; Payton ME; Confer AW; Saliki JT; Ridpath JF; Burge LJ; Duff GC
    Vaccine; 2004 Jan; 22(5-6):643-9. PubMed ID: 14741155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of two intranasal vaccines for the control of bovine respiratory disease in newborn beef calves: A randomized non-inferiority multicentre field trial.
    Masset N; Meurens F; Marie M; Lesage P; Lehébel A; Brisseau N; Assié S
    Vet J; 2020 Sep; 263():105532. PubMed ID: 32928493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus detection by PCR following vaccination of naive calves with intranasal or injectable multivalent modified-live viral vaccines.
    Walz PH; Newcomer BW; Riddell KP; Scruggs DW; Cortese VS
    J Vet Diagn Invest; 2017 Sep; 29(5):628-635. PubMed ID: 28545321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a live intranasal vaccine against parainfluenza type 3 and bovine respiratory syncytial virus in young calves with maternally derived antibodies.
    Metcalfe L; Chevalier M; Tiberghien MP; Jolivet E; Huňady M; Timothy S; Philippe-Reversat C
    Vet Rec Open; 2020; 7(1):e000429. PubMed ID: 33209331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves.
    Palomares RA; Hurley DJ; Bittar JH; Saliki JT; Woolums AR; Moliere F; Havenga LJ; Norton NA; Clifton SJ; Sigmund AB; Barber CE; Berger ML; Clark MJ; Fratto MA
    Vet Immunol Immunopathol; 2016 Oct; 178():88-98. PubMed ID: 27496747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the immune response following subcutaneous versus intranasal modified-live virus booster vaccination against bovine respiratory disease in pre-weaning beef calves that had received primary vaccination by the intranasal route.
    Palomares RA; Bittar JHJ; Woolums AR; Hoyos-Jaramillo A; Hurley DJ; Saliki JT; Ferrer MS; Bullington AC; Rodriguez A; Murray T; Thoresen M; Jones K; Stoskute A
    Vet Immunol Immunopathol; 2021 Jul; 237():110254. PubMed ID: 34034143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of bovine respiratory disease or vaccination with serologic response in dairy heifer calves up to three months of age.
    Windeyer MC; Leslie KE; Godden SM; Hodgins DC; Lissemore KD; LeBlanc SJ
    Am J Vet Res; 2015 Mar; 76(3):239-45. PubMed ID: 25710760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration.
    Ellis J; Gow S; West K; Waldner C; Rhodes C; Mutwiri G; Rosenberg H
    J Am Vet Med Assoc; 2007 Jan; 230(2):233-43. PubMed ID: 17223757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmation of the passive transfer of maternal antibodies to calves following vaccination of pregnant cows with an inactivated Mannheimia haemolytica and Bovine herpes virus type 1 vaccine.
    O'Brien D; Dever M
    Aust Vet J; 2023 May; 101(5):187-192. PubMed ID: 36975715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against bovine respiratory syncytial virus in calves vaccinated with adjuvanted modified live vaccine administered in the face of maternal antibody.
    Kolb EA; Buterbaugh RE; Rinehart CL; Ensley D; Perry GA; Abdelsalam KW; Chase CCL
    Vaccine; 2020 Jan; 38(2):298-308. PubMed ID: 31668818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of immunity to experimental infection with bovine respiratory syncytial virus following intranasal vaccination of young passively immune calves.
    Ellis JA; Gow SP; Mahan S; Leyh R
    J Am Vet Med Assoc; 2013 Dec; 243(11):1602-8. PubMed ID: 24261811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ambient temperature on viral replication and serum antibody titers following administration of a commercial intranasal modified-live infectious bovine rhinotracheitis-parainfluenza-3 virus vaccine to beef cattle housed in high- and moderate-ambient temperature environments.
    Grissett GP; White BJ; Anderson DE; Larson RE; Miesner MD
    Am J Vet Res; 2014 Dec; 75(12):1076-82. PubMed ID: 25419807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of modified-live and inactivated vaccines in boosting responses to bovine respiratory syncytial virus following neonatal mucosal priming of beef calves.
    Ellis J; Gow S; Berenik A; Lacoste S; Erickson N
    Can Vet J; 2018 Dec; 59(12):1311-1319. PubMed ID: 30532289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A spraying applicator device is not required for efficacy of a live intranasal respiratory vaccine in young calves, which improves user convenience.
    Nuijten P; van der Loop J; van Rooij M; Makoschey B; Vertenten G
    Vet Immunol Immunopathol; 2020 Dec; 230():110130. PubMed ID: 33068827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of neonatal vaccination for bovine respiratory disease in the face of a dual challenge with bovine viral diarrhea virus and Mannheimia hemolytica.
    Perkins-Oines S; Dias N; Krafsur G; Abdelsalam K; Perry G; Ensley D; Jones C; Chase CCL
    Vaccine; 2023 May; 41(19):3080-3091. PubMed ID: 37045678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to experimentally induced infection with bovine respiratory syncytial virus following intranasal vaccination of seropositive and seronegative calves.
    Ellis JA; Gow SP; Goji N
    J Am Vet Med Assoc; 2010 May; 236(9):991-9. PubMed ID: 20433400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative serological response in calves to eight commercial vaccines against infectious bovine rhinotracheitis, parainfluenza-3, bovine respiratory syncytial, and bovine viral diarrhea viruses.
    Van Donkersgoed J; van den Hurk JV; McCartney D; Harland RJ
    Can Vet J; 1991 Dec; 32(12):727-33. PubMed ID: 17423913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.